LobbyingIovance Biotherapeutics lobbying by quarter
Iovance Biotherapeutics IOVA's latest lobbying report covers Q2 2023, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.
Iovance BiotherapeuticsIOVA
- Latest quarter
- No record
- Q2 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $360K | 3 |
| Q1 2023 | $170K | 3 |
| Q2 2023 | $0 | 2 |
| Q3 2023 | $0 | 0 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
Policy issues the reports name
- Medicare and Medicaid4 reports
- Health issues2 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES4 reports
- SENATE3 reports
- Centers For Medicare and Medicaid Services (CMS)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseIovance Biotherapeutics | $430K | 2 quarters |
| Avenue Solutions | $50K | 3 quarters |
| W Strategies | $50K | 3 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| NICOLAS MAGALLANES | Senior Advisor - House Republican Conference; Policy Advisor/Professional Staff Member - U.S. Representative Lee Terry/Energy and Commerce Committee; Legislative Correspondent/Legislative Aide - U.S. Senator Lamar Alexander | Q1 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 23/07/20for Q2 2023 | Avenue Solutions | Under $5,000 |
| 23/07/20for Q2 2023 | W Strategies | Under $5,000 |
| 23/04/20for Q1 2023 | W Strategies | Under $5,000 |
| 23/04/20for Q1 2023 | Avenue Solutions | Under $5,000 |
| 23/03/14for Q1 2023 | In-house | $170K |
| 23/01/20for Q4 2022 | In-house | $260K |
| 23/01/20for Q4 2022 | Avenue Solutions | $50K |
| 23/01/19for Q4 2022 | W Strategies | $50K |